Lotemax and Oedema aggravated - a phase IV clinical study of FDA data

Summary:

Oedema aggravated is found among people who take Lotemax, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Lotemax and have Oedema aggravated. It is created by eHealthMe based on reports of 3,801 people who have side effects when taking Lotemax from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

3,801 people reported to have side effects when taking Lotemax.
Among them, 28 people (0.74%) have Oedema aggravated.

What is Lotemax?

Lotemax has active ingredients of loteprednol etabonate. It is often used in uveitis. eHealthMe is studying from 3,871 Lotemax users for its effectiveness, alternative drugs and more.

What is Oedema aggravated?

Oedema aggravated (worse fluid collection in tissue) is found to be associated with 1,589 drugs and 464 conditions by eHealthMe.

Number of Lotemax and Oedema aggravated reports submitted per year:

Gender of people who have Oedema aggravated when taking Lotemax *:

female: 89.29 %
male: 10.71 %

Age of people who have Oedema aggravated when taking Lotemax *:

Common drugs people take besides Lotemax *:

Common side effects people have besides Oedema aggravated *:

Headache (pain in head): 15 people, 53.57%
Anaemia (lack of blood): 15 people, 53.57%
Pain: 15 people, 53.57%
Nausea (feeling of having an urge to vomit): 14 people, 50.00%
Nausea And Vomiting: 13 people, 46.43%
Dizziness: 12 people, 42.86%
Abdominal Pain: 12 people, 42.86%
Diarrhea: 12 people, 42.86%
Gastric Ulcer (stomach ulcer): 12 people, 42.86%
Hypotension (abnormally low blood pressure): 11 people, 39.29%

Common conditions people have *:

Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 35.71%
Anaemia (lack of blood): 3 people, 10.71%
Hypersensitivity: 2 people, 7.14%
Breast Cancer Metastatic: 2 people, 7.14%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 2 people, 7.14%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 7.14%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 7.14%
Constipation: 2 people, 7.14%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 7.14%
Depression: 2 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lotemax and have Oedema aggravated?

Check whether Oedema aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Oedema aggravated and when was it recovered:

Oedema aggravated in Lotemax

Expand to all the drugs that have ingredients of loteprednol etabonate:

Oedema aggravated and drugs with ingredients of loteprednol etabonate

Alternative drugs to, pros and cons of Lotemax:

Lotemax (3,871 reports)

Common Lotemax side effects:

Eye pain: 312 reports
Drug ineffective: 255 reports
Fatigue (feeling of tiredness): 218 reports
Headache (pain in head): 190 reports
Pain: 182 reports
Rashes (redness): 171 reports

Browse all side effects of Lotemax:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oedema aggravated treatments and more:

Oedema aggravated (37 reports)

COVID vaccines that are related to Oedema aggravated:

Common drugs associated with Oedema aggravated:

All the drugs that are associated with Oedema aggravated:

Oedema aggravated (1,589 drugs)

Common conditions associated with Oedema aggravated:

High blood pressure: 3,041 reports
Rheumatoid arthritis: 2,212 reports
Pain: 1,741 reports
Diabetes: 1,364 reports
Multiple myeloma: 1,331 reports
Depression: 1,105 reports
Osteoporosis: 1,088 reports
Atrial fibrillation/flutter: 935 reports

All the conditions that are associated with Oedema aggravated:

Oedema aggravated (464 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loteprednol etabonate (the active ingredients of Lotemax) and Lotemax (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.